About the Event: Thomas Conlon, Chief Scientific Officer of Michelson Philanthropies, will speak on a panel about the future of the mRNA revolution during the Milken Institute’s Future of Health Summit. Messenger RNA, or mRNA, has been a focus of research for...
Maintaining mRNA’s momentum will require continued investment, effective collaboration, and philanthropic contributions, Dr. Thomas Conlon of Michelson Philanthropies said on a panel at the Milken Institute’s Future of Health Summit. Hundreds of medical...
Michelson Philanthropies’ Chief Scientific Officer Thomas Conlon joins the 2022 Milken Institute Future of Health Summit alongside a panel of vaccine development and biomedical experts to discuss the potential and advancements of mRNA. Messenger RNA, or mRNA,...